An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.

Inflammatory angiogenesis and vascular remodeling play key roles in the chronic inflammatory skin disease psoriasis, but little is known about the molecular mediators of vascular activation. Based on the reported elevated mRNA levels of the angiogenic chemokine stromal cell-derived factor-1 (SDF-1)...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvana Zgraggen, Reto Huggenberger, Katrin Kerl, Michael Detmar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093665&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850191503416098816
author Silvana Zgraggen
Reto Huggenberger
Katrin Kerl
Michael Detmar
author_facet Silvana Zgraggen
Reto Huggenberger
Katrin Kerl
Michael Detmar
author_sort Silvana Zgraggen
collection DOAJ
description Inflammatory angiogenesis and vascular remodeling play key roles in the chronic inflammatory skin disease psoriasis, but little is known about the molecular mediators of vascular activation. Based on the reported elevated mRNA levels of the angiogenic chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 in psoriasis, we investigated the relevance of the SDF-1/CXCR4 axis in two experimental models of chronic psoriasis-like skin inflammation. The cutaneous expression of both SDF-1 and CXCR4 was upregulated in the inflamed skin of K14-VEGF-A transgenic mice and in imiquimod-induced skin inflammation, with expression of CXCR4 by blood vessels and macrophages. Treatment with the CXCR4 antagonist AMD3100 potently inhibited skin inflammation in both models, associated with reduced inflammatory angiogenesis and inflammatory cell accumulation, including dermal CD4+ cells and intraepidermal CD8+ T cells. Similar anti-inflammatory effects were seen after treatment with a neutralizing anti-SDF-1 antibody. In vitro, inhibition of CXCR4 blocked SDF-1-induced chemotaxis of CD11b+ splenocytes, in agreement with the reduced number of macrophages after in vivo CXCR4 blockade. Our results reveal an important role of the SDF-1/CXCR4 axis in skin inflammation and inflammatory angiogenesis, and they indicate that inhibition of the SDF-1/CXCR4 axis might serve as a novel therapeutic strategy for chronic inflammatory skin diseases.
format Article
id doaj-art-4b4e71a7d3fd40ad810f246bf2a04c89
institution OA Journals
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-4b4e71a7d3fd40ad810f246bf2a04c892025-08-20T02:14:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9366510.1371/journal.pone.0093665An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.Silvana ZgraggenReto HuggenbergerKatrin KerlMichael DetmarInflammatory angiogenesis and vascular remodeling play key roles in the chronic inflammatory skin disease psoriasis, but little is known about the molecular mediators of vascular activation. Based on the reported elevated mRNA levels of the angiogenic chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 in psoriasis, we investigated the relevance of the SDF-1/CXCR4 axis in two experimental models of chronic psoriasis-like skin inflammation. The cutaneous expression of both SDF-1 and CXCR4 was upregulated in the inflamed skin of K14-VEGF-A transgenic mice and in imiquimod-induced skin inflammation, with expression of CXCR4 by blood vessels and macrophages. Treatment with the CXCR4 antagonist AMD3100 potently inhibited skin inflammation in both models, associated with reduced inflammatory angiogenesis and inflammatory cell accumulation, including dermal CD4+ cells and intraepidermal CD8+ T cells. Similar anti-inflammatory effects were seen after treatment with a neutralizing anti-SDF-1 antibody. In vitro, inhibition of CXCR4 blocked SDF-1-induced chemotaxis of CD11b+ splenocytes, in agreement with the reduced number of macrophages after in vivo CXCR4 blockade. Our results reveal an important role of the SDF-1/CXCR4 axis in skin inflammation and inflammatory angiogenesis, and they indicate that inhibition of the SDF-1/CXCR4 axis might serve as a novel therapeutic strategy for chronic inflammatory skin diseases.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093665&type=printable
spellingShingle Silvana Zgraggen
Reto Huggenberger
Katrin Kerl
Michael Detmar
An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
PLoS ONE
title An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
title_full An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
title_fullStr An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
title_full_unstemmed An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
title_short An important role of the SDF-1/CXCR4 axis in chronic skin inflammation.
title_sort important role of the sdf 1 cxcr4 axis in chronic skin inflammation
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093665&type=printable
work_keys_str_mv AT silvanazgraggen animportantroleofthesdf1cxcr4axisinchronicskininflammation
AT retohuggenberger animportantroleofthesdf1cxcr4axisinchronicskininflammation
AT katrinkerl animportantroleofthesdf1cxcr4axisinchronicskininflammation
AT michaeldetmar animportantroleofthesdf1cxcr4axisinchronicskininflammation
AT silvanazgraggen importantroleofthesdf1cxcr4axisinchronicskininflammation
AT retohuggenberger importantroleofthesdf1cxcr4axisinchronicskininflammation
AT katrinkerl importantroleofthesdf1cxcr4axisinchronicskininflammation
AT michaeldetmar importantroleofthesdf1cxcr4axisinchronicskininflammation